Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05116150
Other study ID # 112-1819 EXP
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2019
Est. completion date December 1, 2019

Study information

Verified date November 2021
Source California Baptist University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was to examine the additive benefits with combined grape seed extract (GSE) and L-citrulline supplementation on hemodynamic responses to dynamic exercise, 11 young, healthy males were recruited for this study.


Description:

The investigators aimed the additive effects of combined grape seed extract (GSE) and L-citrulline supplementation on hemodynamic responses to dynamic exercise, 11 young, healthy males were recruited for this study. Effects of 7 days of combined GSE with L-citrulline supplementation on systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP), cardiac output (CO), total vascular conductance (TVC), and oxygen consumption (O2) were examined at rest and during cycling exercise.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date December 1, 2019
Est. primary completion date December 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - healthy males Exclusion Criteria: - cardiovascular and/or pulmonary disease, musculoskeletal disorders, or medications that prevent the safe completion of the exercise protocol

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Grape seed extract
Effects of 7 days of combined GSE with L-citrulline supplementation on hemodynamic responses at rest and during cycling exercise.
Placebo
Effects of 7 days of placebo supplementation on hemodynamic responses at rest and during cycling exercise.

Locations

Country Name City State
United States California Baptist University Riverside California

Sponsors (1)

Lead Sponsor Collaborator
California Baptist University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Systolic blood pressure (mmHg) by sphygmomanometer 7 days
Primary Diastolic blood pressure (mmHg) by sphygmomanometer 7 days
Primary Mean arterial pressure (mmHg) calculated (MAP = (SBP-DBP)/3 + DBP 7 days
Primary Heart rate (bpm) measured using Physio Flow (non-invasive device) 7 days
Primary Stroke volume (ml) measured using Physio Flow (non-invasive device) 7 days
Primary Cardiac output (l/min) calculated: HR (bpm) x SV (ml) 7 days
Primary Total vascular conductance (ml/min/mmHg) calculated: CO (ml/min) / MAP (mmHg) 7 days
See also
  Status Clinical Trial Phase
Completed NCT03003988 - Physiological Effects of Creatine Supplementation in Active Males N/A
Completed NCT05945771 - Effects of Acute Grape Seed Extract Supplementation on Muscle Metaboreflex in Healthy Young Individuals N/A
Not yet recruiting NCT06256744 - Resistance Exercise-induced Anabolism in Youths and Adults N/A
Completed NCT03326934 - Impact of Dark Chocolate on Visual Performance N/A
Completed NCT04988919 - Consumption of 4D Dietary Supplement on Perceptual-Cognitive and Visual-Motor Performance N/A